Print pageHome » News: FDA Reorganizes; Appoints Ex-Dartmouth Dean As Deputy Commissioner
News: FDA Reorganizes; Appoints Ex-Dartmouth Dean As Deputy Commissioner
WSJ.com
PharmaManufacturing.com
07/14/2011
The FDA named Stephen P. Spielberg, a former senior drug-company official and Dartmouth Medical School dean, as its new deputy commissioner overseeing much of the agency's operations.
Commissioner Margaret A. Hamburg selected Spielberg to the new position of Deputy Commissioner for Medical Products and Tobacco. The appointment was part of a reorganization at the top of the nation's leading medical- and food-safety agency.
Dr. Spielberg, a pediatrician and pharmacologist, most recently has served as director of personalized medicine at Children's Mercy Hospital in Kansas City.
Read the full story from WSJ.com here.
More News:
-
05/21/2013
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
-
05/21/2013
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
-
05/21/2013
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
-
05/17/2013
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
-
05/16/2013
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
-
05/16/2013
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
-
05/15/2013
Rapid Micro Biosystems Offers Workshops at New European Headquarters in MunichFrom Rapid Micro Biosystems
Company hosts hands-on demonstrations of its Growth Direct System
-
05/13/2013
Amgen, Zhejiang Beta Pharma Form Joint VentureFrom FOX Business
Amgen will form a joint venture with Chinese pharma firm to bring its colon cancer drug Vectibix to the Chinese market
-
05/13/2013
Academic Tech Transfer Collaboration Required for Pharma R&D ModelFrom IT News Online
Pharma R&D Model Needs Academic Tech Transfer Collaboration for the Future of Drug Innovation Says New Report
-
05/09/2013
CEM Wins Solid-Phase Peptide Synthesis Patent DisputeFrom CEM
CEM's European Patent covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding
- All news »
Get Connected Now!
- Featured White Papers
Sponsored Links
